valerates has been researched along with Cancer of Head in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruner, DW; Claussen, H; Fedirko, V; Higgins, KA; Maner-Smith, KM; Miller, AH; Paul, S; Peng, G; Richard Johnston, H; Saba, NF; Shin, DM; Wommack, EC; Xiao, C | 1 |
| Hamauchi, S; Mori, K; Ogawa, H; Onitsuka, T; Onoe, T; Suzuki, M; Yamashita, A; Yokota, T; Yoshida, Y; Yurikusa, T | 1 |
| Asada, Y; Imai, T; Ishida, E; Katagiri, K; Matsuura, K; Sadayasu, R; Sagai, S; Saijo, S; Saito, D; Wada, H | 1 |
2 trial(s) available for valerates and Cancer of Head
| Article | Year |
|---|---|
A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Topics: Adult; Aged; Chemoradiotherapy; Dipeptides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Quality of Life; Stomatitis; Valerates; Young Adult | 2018 |
Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Dietary Supplements; Dipeptides; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Severity of Illness Index; Treatment Outcome; Valerates | 2014 |
1 other study(ies) available for valerates and Cancer of Head
| Article | Year |
|---|---|
Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study.
Topics: Butyrates; Fatigue; Fatty Acids, Volatile; Head and Neck Neoplasms; Humans; Prospective Studies; Valerates | 2023 |